Back

Geneseeq Technology

Leveraging cutting-edge genomic profiling technology to advance cancer care

Geneseeq is a research-driven company that provides next generation sequencing (NGS) technology to accelerate precision cancer care. With headquarters in both Canada and China, Geneseeq focuses on clinical genetic testing and translational research covering all cancers and sample types. The company provides a full suite of next generation sequencing services to facilitate the research and creative endeavors of those in academia and industry. The company offers both pan-cancer panels analyzing more than 400 genes and cancer-type specific gene panels to help match patients to optimal treatments, including targeted therapy and immunotherapy.

Click on the featured content below to learn how Geneseeq, in collaboration with IDT, is accelerating precision cancer research!

Collaborator content

Whole Exome Sequencing Handbook

In this three-part series handbook, we provide an overview of one of Geneseeq’s published studies and the new discoveries that were made from using our xGen™ Exome Hyb Panel.

Learn more

Geneseeq Joins IDT Align Program

The Align Program is focused on bridging researchers with preferred sequencing service providers to further advance their genomic studies. 

Learn more

Whole exome sequencing reveals timing and origins of local and distant metastasis in lung cancer

In this webinar series, Dr. Bao walks us through how his team at Geneseeq is leveraging IDT’s xGen™ Exome Hyb Panel to advance their teams oncology research program.

Learn more